Innovent Biologics Inc Cash Flow Quality Index
Innovent Biologics Inc cash flow quality index. Innovent Biologics Inc (6IB) has a Cash Flow Quality Index of 12.29x as of December 2025. Operating cash flow of €10.00 Billion exceeds net income of €813.57 Million, indicating high earnings quality where cash backs reported profits. See financial agility of Innovent Biologics Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Innovent Biologics Inc (2025–2025)
Cash flow quality index of Innovent Biologics Inc from 2025 to 2025. Historical Cash Flow Quality Index for Innovent Biologics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Innovent Biologics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Innovent Biologics Inc Cash Flow Quality Index by Year (2025–2025)
Innovent Biologics Inc cash flow quality index by year from 2025 to 2025. Year-by-year earnings quality comparison for Innovent Biologics Inc. For the full cash flow conversion analysis, see 6IB operating cash flow.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 12.29x | €10.00 Billion | €813.57 Million | — |